NCT02004132已完成1 期
A Phase 1, Single-Dose Study to Evaluate Testosterone on Clothing After Axiron® Use in Healthy Male Subjects
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 12
- 试验地点
- 1
- 主要终点
- Amount of Testosterone on T-shirts
研究概览
简要总结
The study involves application of Axiron to each underarm. The study will evaluate the transfer of testosterone from underarms to the clothing items that the participant is wearing and other fabric items washed with participant's' clothes. The study is approximately 6 days, not including screening. Screening is required within 28 days prior to the start of the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Are overtly healthy males, as determined by medical history and physical examination, or males who have been on stable medication for at least 1 month and have no significant clinical conditions.
- •Agree to use a reliable method of birth control (for example: condom or vasectomy) during the study and for 3 months following the Axiron dose
- •Have clinical laboratory test results within the normal reference range for the population or investigator site, or results with acceptable deviations that are judged to be not clinically significant by the investigator
- •Are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
- •Have given written informed consent approved by Lilly and the ethical review board (ERB) governing the site
排除标准
- •Are currently enrolled in a clinical trial involving an investigational product or off-label use of a drug or device, or are concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study
- •Are participants who have previously completed or withdrawn from this study or any other study investigating Axiron in the past 3 months
- •Have known allergies to testosterone solution, related compounds, or any components of the formulation, or history of significant atopy
- •Have an abnormality in the 12-lead electrocardiogram (ECG) that, in the opinion of the investigator, increases the risks associated with participating in the study
- •Have an abnormal blood pressure as determined by the investigator
- •Have a history of or current cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological, or neurological disorders constituting a risk when taking the study medication or that could interfere with the interpretation of the data
- •Have had lymphoma, leukemia, or any malignancy within the past 5 years except for basal cell or squamous epithelial carcinomas of the skin that have been resected with no evidence of metastatic disease for 3 years
- •Regularly use known drugs of abuse and/or show positive findings on urinary drug screening
- •Show evidence of human immunodeficiency virus (HIV) infection and/or positive human HIV antibodies
- •Show evidence of hepatitis C and/or positive hepatitis C antibody
- •Show evidence of hepatitis B and/or positive hepatitis B surface antigen
- •Use of any topical testosterone replacement therapy within the 3 months prior to study entry through study discharge, except for use of Axiron as directed by study procedures
- •Use of parenteral testosterone replacement (testosterone enthanate, testosterone cypionate) within the 30 days prior to screening. Use of long acting intramuscular testosterone undecanoate 6 months prior to screening, or use of testosterone pellets 12 months prior to screening
- •Have a dermatologic condition in the underarm area that might be exacerbated by topical testosterone replacement therapy, in the opinion of the investigator
- •In the opinion of the investigator or sponsor, are unsuitable for inclusion in the study
研究组 & 干预措施
Axiron
Experimental
Axiron administered topically via metered dose pump to each underarm on Day 1
干预措施: Axiron (Drug)
结局指标
主要结局
Amount of Testosterone on T-shirts
时间窗: 12 hours after application of study drug
This is a summary of the amounts of testosterone measured on a 10 centimeters (cm) × 10 cm of material excised from the underarm area of participant's unwashed t-shirt halves.
次要结局
- Amount of Testosterone on Unworn Textiles Laundered With the Testosterone Exposed T-shirts(12 hours after application of study drug)
- Amount of Testosterone Following Laundering(12 hours after application of study drug)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male SubjectsHealthy SubjectsNCT02116907Eisai Inc.7
招募中
1 期
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)NCT05885412Rocket Pharmaceuticals Inc.9
已完成
1 期
A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male SubjectsAnesthesiaSedationNCT04029766Sichuan Haisco Pharmaceutical Group Co., Ltd13
已完成
1 期
A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic ImpairmentHepatic ImpairmentNCT00768209VIVUS LLC18
已完成
1 期
A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001Idiopathic Pulmonary FibrosisNCT04540770HuniLife Biotechnology, Inc.24